Sun, Jie http://orcid.org/0000-0001-9184-5049
Lepor, Norman E.
Cantón, Gádor
Contreras, Laurn
Hippe, Daniel S.
Isquith, Daniel A.
Balu, Niranjan
Kedan, Ilan
Simonini, Americo A.
Yuan, Chun
Zhao, Xue-Qiao
Hatsukami, Thomas S.
Funding for this research was provided by:
Regeneron Pharmaceuticals
Article History
Received: 16 July 2020
Accepted: 21 November 2020
First Online: 3 January 2021
Compliance with ethical standards
:
: Norman E. Lepor: Speakers bureau: Amgen, Sanofi, and Regeneron; Research support: The Medicines Company, Esperion, Amgen, Sanofi, and Regeneron. Daniel S. Hippe: Research support: GE Healthcare, Philips Healthcare, Toshiba America Medical Systems, Siemens Medical Solutions USA. Chun Yuan: Research support: Philips Healthcare. Xue-Qiao Zhao: Research support: Amgen, AstraZeneca. Thomas S. Hatsukami: Research support: Philips Healthcare. Other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
: All study participants provided informed consent.
: All authors have seen and approved the manuscript being submitted.
: Approved by the Western Institutional Review Board.